<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-19T11:13:28+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>药融资丨国投招商领投CAR-T头部企业，合源生物完成4.5亿元新一轮融资，自主知识产权CAR-T产品进入临床II期</title>
    <updated>2020-11-18T22:44:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/dpqacvCPoM0-LhGJkmdobw</id>
    <link href="https://mp.weixin.qq.com/s/dpqacvCPoM0-LhGJkmdobw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物医药供应链国产品牌的产业化之路丨医麦新观察</title>
    <updated>2020-11-18T22:44:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/ndN6ranhMwT9C4sphUi4Rg</id>
    <link href="https://mp.weixin.qq.com/s/ndN6ranhMwT9C4sphUi4Rg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>mRNA疫苗研发系列公开课第一场精彩回顾 | 医麦新观察</title>
    <updated>2020-11-18T22:44:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/VoScbJD4yQt5d_yKANIrcQ</id>
    <link href="https://mp.weixin.qq.com/s/VoScbJD4yQt5d_yKANIrcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物医药企业如何从容应对人类遗传资源监管及最新注册法规？</title>
    <updated>2020-11-18T22:44:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/_vCFOBCIEtSJT1UGnOjuKg</id>
    <link href="https://mp.weixin.qq.com/s/_vCFOBCIEtSJT1UGnOjuKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>周剑峰教授：进一步优化CAR-T疗法向终极治疗方向发展，更好地融合于现有治疗体系</title>
    <updated>2020-11-18T22:44:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/gOnyDa6jRsn2-d0uLeBNCw</id>
    <link href="https://mp.weixin.qq.com/s/gOnyDa6jRsn2-d0uLeBNCw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」中盛溯源联合创始人张颖：推动中国iPSC来源细胞药物研发达到发达国家同等水平</title>
    <updated>2020-11-18T22:44:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/PrxTj1lJkPjZpah1fW1S2A</id>
    <link href="https://mp.weixin.qq.com/s/PrxTj1lJkPjZpah1fW1S2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>利用人工智能的力量快速设计寡核苷酸药物，BioMarin与AI新贵公司达成合作丨医麦猛爆料</title>
    <updated>2020-11-18T22:44:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/_QWE2-jEMCNBt1erdYhfhQ</id>
    <link href="https://mp.weixin.qq.com/s/_QWE2-jEMCNBt1erdYhfhQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>1000万美元IND里程碑付款，礼来和Dicerna合作的RNAi疗法将启动心脏代谢性疾病的临床研究丨医麦猛爆料</title>
    <updated>2020-11-18T13:26:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/vL4u_Pc2WxD8mbd-viS-nw</id>
    <link href="https://mp.weixin.qq.com/s/vL4u_Pc2WxD8mbd-viS-nw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>4-1BB/5T4双抗即将进入临床开发阶段，国内哪些公司还在关注丨医麦猛爆料</title>
    <updated>2020-11-18T13:26:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/Y5hpsW6zMTGvQ5Xkbb99LA</id>
    <link href="https://mp.weixin.qq.com/s/Y5hpsW6zMTGvQ5Xkbb99LA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>有效率高达94.5%，EMA启动Moderna新冠候选疫苗的滚动审查程序丨医麦猛爆料</title>
    <updated>2020-11-18T13:26:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/aHAFCTnbOfvOBVT6DGYlXw</id>
    <link href="https://mp.weixin.qq.com/s/aHAFCTnbOfvOBVT6DGYlXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>朱军教授：国内CAR-T研究数量多但原始创新不够，未来应深化研究做出中国特色</title>
    <updated>2020-11-18T13:26:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/1PPiRlJt3eH4f7F58DXziQ</id>
    <link href="https://mp.weixin.qq.com/s/1PPiRlJt3eH4f7F58DXziQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶向NKG2D，Nkarta“现货”CAR-NK完成首例患者给药 | 医麦猛爆料</title>
    <updated>2020-11-16T22:56:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/T6qkWAywg1alQUBgkf1F8A</id>
    <link href="https://mp.weixin.qq.com/s/T6qkWAywg1alQUBgkf1F8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>天境、信达、康方公布CD47单抗最新临床研究数据，哪些公司还在押注CD47 | 医麦猛爆料</title>
    <updated>2020-11-16T22:56:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/dxlmVSutg6q2xGG2l4JWJw</id>
    <link href="https://mp.weixin.qq.com/s/dxlmVSutg6q2xGG2l4JWJw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>长达92周的耐久性！AAV基因疗法大幅度降低湿性AMD患者的治疗负担丨医麦猛爆料</title>
    <updated>2020-11-16T22:56:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/r4kJGGrcw8HCuE-mXlmJ2Q</id>
    <link href="https://mp.weixin.qq.com/s/r4kJGGrcw8HCuE-mXlmJ2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」获近亿元融资，基因编辑公司瑞风生物预计明年准备申报β地贫疗法IND</title>
    <updated>2020-11-16T22:56:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/GViRtb0fVa4e4RjCcohW3w</id>
    <link href="https://mp.weixin.qq.com/s/GViRtb0fVa4e4RjCcohW3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅来袭】药物警戒及受试者权益保护国际研讨会暨CIOMS《药物性肝损伤（DILI）国际共识》发布会即将召开！</title>
    <updated>2020-11-16T22:56:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/2f2759S7SfHlS1wX1stUVQ</id>
    <link href="https://mp.weixin.qq.com/s/2f2759S7SfHlS1wX1stUVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨深圳普瑞金生物药业有限公司完成1.4亿元B轮融资，并启动港股IPO</title>
    <updated>2020-11-15T23:31:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/GiDi8Y9qgV8w_LL9GZb30w</id>
    <link href="https://mp.weixin.qq.com/s/GiDi8Y9qgV8w_LL9GZb30w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>西比曼生物更新CD19/CD20双特异性CAR-T临床进展，治疗复发难治性B-NHL数据亮眼丨医麦猛爆料</title>
    <updated>2020-11-15T23:31:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/n0Sx3Viao01a4GzZlRj43A</id>
    <link href="https://mp.weixin.qq.com/s/n0Sx3Viao01a4GzZlRj43A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从License-in到License-out，中国生物创新型药企走出国门 | 医麦新观察</title>
    <updated>2020-11-15T23:31:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/AAl1rnsql48jEOY1Y5g-Og</id>
    <link href="https://mp.weixin.qq.com/s/AAl1rnsql48jEOY1Y5g-Og" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>暴露肿瘤细胞，隐藏健康细胞！CD33 CAR-T搭配新型造血干细胞对抗AML丨医麦猛爆料</title>
    <updated>2020-11-15T23:31:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/ygYTvzRpqjJLsQaQjoYdCg</id>
    <link href="https://mp.weixin.qq.com/s/ygYTvzRpqjJLsQaQjoYdCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>